Z
The company utilizes machine learning algorithms to enhance the efficacy and reduce the immunogenicity of immunotherapies for cancer and autoimmune diseases. By identifying and developing treatments that minimize immune responses, the platform aims to provide patients with safer and more effective therapeutic options.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The company utilizes machine learning algorithms to enhance the efficacy and reduce the immunogenicity of immunotherapies for cancer and autoimmune diseases. By identifying and developing treatments that minimize immune responses, the platform aims to provide patients with safer and more effective therapeutic options.